Physician profile
John Costello
NPI 1699037291
$32,587.08
in general payments reported to CMS, 2019-2025
35 companies · $6,639 in 2025
The $6,639 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $856 · 2021: $2,605 · 2022: $2,897 · 2023: $2,531 · 2024: $1,646 · 2025: $6,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,120 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Travel and Lodging: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,120.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Travel and Lodging | $695.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $12,734.63 | 2019-2020 | |
| Boston Scientific Corporation | $7,552.26 | 2020-2025 | Farapulse, Watchman Access System, Watchman Flx |
| Abbott Laboratories | $3,675.56 | 2019-2025 | Aveir, Perclose Prostyle, Triclip |
| Biosense Webster, INC. | $1,630.67 | 2019-2025 | Octaray Mapping Catheter, Carto 3, Nuvision Ice Catheter |
| Impulse Dynamics (USA) INC. | $1,410.72 | 2021-2025 | Optimizer, Optimizer |
| Biotronik INC. | $1,183.37 | 2019-2023 | Biomonitor |
| Philips North America LLC | $869.19 | 2023-2024 | (Ao0) Igt Devices Intracardiac |
| Atricure, INC. | $858.90 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Zoll Respicardia, INC. | $352.22 | 2021 | |
| Elutia, INC. | $345.43 | 2021-2022 | |
| Cvrx, INC. | $340.86 | 2022-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $260.66 | 2020-2025 | Lifevest |
| Pfizer INC. | $201.52 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $171.28 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $116.11 | 2022-2023 | Verquvo |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Costello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.